HLHS Cardiomyocytes Fail to Adapt to Mechanical Load in a Human Cell Model
Human cardiomyocytes carry a constant mechanical burden, and in hypoplastic left heart syndrome that burden is altered from the start. After staged palliation, the right ventricle must support systemic circulation, leaving the heart to function under a loading pattern it was never meant to sustain. A new bioRxiv preprint uses patient-derived induced pluripotent stem cells to examine whether that abnormal mechanical setting is reflected at the cellular level, and the answer is unsettling: the cells derived from patients with HLHS did not respond to stretch the way control cardiomyocytes did.
The study asked a straightforward question with major clinical implications. If the disease is driven not only by abnormal anatomy but also by a defect in how cardiac muscle senses and adapts to force, then the failing single ventricle may be dealing with a cellular programming problem as much as a hemodynamic one. The work focused on iPSC-derived cardiomyocytes from two unaffected donors and four patients with HLHS, then compared static culture against a 48-hour regimen of cyclic 20% uniaxial stretch at 1 Hz.
Modest Baseline Defects Became More Concerning Under Stretch
In static culture, HLHS cardiomyocytes already showed modest abnormalities. Sarcomere organization was less robust than in control tissues, and calcium transient morphology was also altered. Those findings matter because sarcomere alignment and calcium cycling sit at the center of contractile efficiency; when either becomes disordered, the myocardium has less reserve for the demands of pressure overload and chronic volume stress.
The more striking signal emerged once mechanical force was applied. Control cardiomyocytes responded to cyclic stretch with faster calcium transient rise time, a pattern consistent with a normal adaptive response to increased workload. Among the four HLHS cell lines, that response appeared in only one. The others did not exhibit the same improvement in calcium kinetics, suggesting a failure of mechanotransduction rather than a uniform response across the disease cohort.
A single favorable response in four patient lines is not a reassuring edge case. It points to biological heterogeneity inside a syndrome often treated as a single clinical entity.
Calcium Handling Failed to Recalibrate
Calcium dynamics are not a side feature of contractility; they are the machinery of contraction itself. When a cardiomyocyte encounters higher mechanical demand, it normally adjusts calcium handling to preserve force generation and relaxation timing. In this preprint, the stretch stimulus produced that expected shift in control cells, but not in HLHS cells as a group.
Bulk RNA sequencing added a molecular layer to the phenotype. All four HLHS lines failed to upregulate calcium handling genes and sarcomere-associated genes in response to stretch, in contrast to the control cells. That transcriptional silence provides a plausible explanation for the physiologic defect seen in the calcium assays. If the cell cannot increase expression of the proteins needed for excitation-contraction coupling and structural remodeling, it cannot mount a durable adaptive response to sustained load.
Inflammatory Signaling Rose Instead of Adaptive Remodeling
Mechanical strain did not simply leave HLHS cardiomyocytes unchanged. It pushed them toward inflammatory signaling. Stretch activated inflammatory pathways in the HLHS cells, while control cells did not show the same response. In a myocardium already vulnerable to chronic stress, a switch toward inflammation can be damaging because inflammatory programs can interfere with contractile protein homeostasis, perturb calcium cycling, and encourage maladaptive remodeling.
This is where the biology becomes clinically relevant. The single ventricle in HLHS is not only pumping harder; it may also be sensing force in a way that translates mechanical load into a stress response rather than an adaptive one. That shift could help explain why some patients progress toward heart failure despite technically successful surgical palliation. The ventricle may have limited capacity to translate stretch into useful remodeling and instead may translate it into inflammatory activation and functional decline.
The investigators frame this as defective mechanoadaptation, and the data support that interpretation. The problem is not limited to anatomy. It extends into the way the cardiomyocyte itself interprets force.
Why This Model Matters for a Congenital Heart Defect
HLHS remains a severe congenital heart defect with an incomplete mechanistic explanation. Clinical care has improved survival through staged surgery, yet late ventricular failure remains a major threat. A human iPSC platform offers a way to separate patient-specific cellular behavior from the complexities of postoperative anatomy, neurohormonal compensation, and variable surgical histories. In that sense, the model is useful because it isolates the myocardium’s response to one of the defining physiologic stresses of the disease: cyclic stretch.
The choice of 20% uniaxial stretch at 1 Hz is biologically meaningful because it imposes a patterned mechanical load, closer to the kind of rhythmic deformation a ventricle experiences in vivo than static culture can provide. Under those conditions, control cells did what healthy cardiac tissue should do: they adapted. HLHS cells often did not. The difference is especially relevant for a disease in which the right ventricle is required to perform as the systemic ventricle, a task associated with chronic mechanical strain over time.
There is also translational value in the gene-expression signatures. Calcium handling genes, sarcomere-associated genes, and inflammatory pathways may form a panel of candidate biomarkers for future work. If similar patterns can be confirmed in patient tissue or blood-based surrogates, they could help refine risk stratification or identify patients whose myocardium is already drifting toward maladaptive remodeling.
Therapeutic Questions Raised by a Stretch-Sensing Defect
The preprint does not offer a therapy, and it should not be read as one. What it does offer is a mechanistic foothold. If HLHS cardiomyocytes fail to adapt to mechanical load because they do not properly upregulate calcium-handling and structural genes, then future interventions might need to target mechanosensitive signaling, excitation-contraction coupling, or the inflammatory response that follows stretch. The findings also suggest that therapies aimed only at hemodynamics may leave an important cellular defect untouched.
Because the study used a preclinical model, the work remains one step removed from patient outcomes. Yet the direction of the signal is hard to ignore: control cardiomyocytes adapted to cyclic stretch; HLHS cardiomyocytes largely did not; and the diseased cells shifted toward inflammation rather than productive remodeling. Those three observations fit together into a coherent pathophysiologic model.
The unresolved questions are practical ones. Whether the same mechanoadaptive defect appears in larger patient sets, how it relates to clinical severity, and whether it can be modified pharmacologically or through tissue engineering remain open. For now, the preprint argues that in HLHS, the myocardium may be built not only with structural constraints, but with a built-in inability to respond normally when force increases.